VA-CMHC-Yale Schizophrenia Research Program
Mission
To study the pathophysiology of schizophrenia and to develop better treatments for it.
Research Portfolio
- Laboratory Studies of Psychotomimetic Drugs in Healthy Humans
- Development of stand-alone and add-on treatments for positive, negative and cognitive symptoms of schizophrenia
- Brain imaging (PET, MRI, EEG)
- Cognitive Remediation
- Genetics
Who is eligible?
- Individuals diagnosed with Schizophrenia or other psychotic disorders.
- Healthy Controls
Leadership
- Deepak Cyril D'Souza, MD, Associate Professor of Psychiatry, Clinic Chief
- Mohini Ranganathan, MD, Assistant Professor of Psychiatry, Associate Chief
Yale Faculty
Deepak D'Souza
Associate Professor of Psychiatry
Director Schizophrenia Research Program VACHS
Director, Neurobiological Studies Unit, VACHS
Director, VA-CMHC Schizophrenia Research Clinic
Mohini Ranganathan
Assistant Professor of Psychiatry
R. Andrew Sewell
Assistant Professor of Psychiatry
Patrick Skosnik
Assistant Professor of Psychiatry
Zoran Zimolo
Assistant Professor of Psychiatry
Contact Us
For more information about the clinic and our research programs, please call Kimberlee Forselius at 203-974-7540.
Locations
109479falsetrue
